FIRST TRUST ADVISORS LP – Vertex Pharmaceuticals Incorporated Transaction History
FIRST TRUST ADVISORS LP portfolio value:
$104.49M
portfolio value
FIRST TRUST ADVISORS LP quarter portfolio value change:
+2.75%
quarter
Vertex Pharmaceuticals Incorporated 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -64.94% | -668.54K shares | -185.59M | $289.54 | 360.89K |
Q2 2022 | share | Increase | +133.53% | 588.62K shares | 175.04M | $281.79 | 1.02M |
Q1 2022 | share | Decrease | -15.46% | -80.61K shares | 534K | $260.97 | 440.81K |
Q4 2021 | share | Increase | +6.27% | 30.75K shares | 25.50M | $222.45 | 521.42K |
Q3 2021 | share | Increase | +22.88% | 91.35K shares | 8.48M | $181.39 | 490.67K |
Q2 2021 | share | Increase | +3.03% | 11.73K shares | -2.76M | $201.63 | 399.31K |
Q1 2021 | share | Decrease | -4.07% | -16.43K shares | -12.19M | $214.89 | 387.58K |
Q4 2020 | share | Decrease | -51.31% | -425.74K shares | -130.30M | $236.34 | 404.01K |
Q3 2020 | share | Increase | +2.18% | 17.70K shares | -9.95M | $272.12 | 829.76K |
Q2 2020 | share | Increase | +63.91% | 316.63K shares | 117.86M | $290.31 | 812.05K |
Q1 2020 | share | Increase | +38.78% | 138.44K shares | 39.72M | $237.95 | 495.42K |
Q4 2019 | share | Decrease | -20.04% | -89.45K shares | 2.52M | $218.95 | 356.97K |
Q3 2019 | share | Decrease | -33.19% | -221.79K shares | -46.90M | $169.42 | 446.43K |
Q2 2019 | share | Decrease | -9.40% | -69.33K shares | -13.13M | $183.38 | 668.23K |
Q1 2019 | share | Increase | +4.11% | 29.08K shares | 18.27M | $183.95 | 737.56K |
Q4 2018 | share | Decrease | -1.39% | -9.97K shares | -21.07M | $165.71 | 708.47K |
Q3 2018 | share | Increase | +39.87% | 204.78K shares | 51.17M | $192.74 | 718.45K |
Q2 2018 | share | Increase | +7.70% | 36.70K shares | 9.56M | $169.96 | 513.67K |
Q1 2018 | share | Decrease | -12.07% | -65.46K shares | -3.55M | $162.98 | 476.97K |
Q4 2017 | share | Decrease | -2.27% | -12.58K shares | -3.09M | $149.86 | 542.43K |
Q3 2017 | share | Decrease | -14.16% | -91.51K shares | 1.06M | $152.04 | 555.02K |
Q2 2017 | share | Increase | +60.28% | 243.15K shares | 39.20M | $128.87 | 646.53K |
Q1 2017 | share | Decrease | -3.33% | -13.90K shares | 13.36M | $109.35 | 403.38K |
Q4 2016 | share | Increase | +15.83% | 57.01K shares | -677K | $73.67 | 417.29K |
Q3 2016 | share | Decrease | -13.51% | -56.28K shares | -4.41M | $87.21 | 360.27K |
Q2 2016 | share | Decrease | -4.01% | -17.40K shares | 1.33M | $86.02 | 416.56K |
Q1 2016 | share | Decrease | -55.71% | -545.76K shares | -88.78M | $79.49 | 433.96K |